Generic drugs are drugs with the same qualitative and quantitative composition in terms of active substances and the same pharmaceutical form as the reference drug. The bioequivalence of generic drugs in relation to the reference drug has also been guaranteed through appropriate bioavailability studies. The Tecnimede Group develops about a dozen new generic drugs every year.

The development and availability of generic medicines enables national healthcare systems and the user to save very considerable amounts of money while ensuring the safety, efficacy, and quality of the medicine.

The billions of euros of savings that generic medicines produce every year boost the sustainability of healthcare systems, improve the accessibility of medicines to the population, free up capital for essential treatments and services for patients, and stimulate research into new therapeutic solutions.